Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Narrative)

v3.20.1
Subsequent Events (Details Narrative) - USD ($)
1 Months Ended 4 Months Ended 12 Months Ended
May 14, 2020
Apr. 17, 2020
Apr. 10, 2020
Mar. 31, 2020
Feb. 05, 2020
Dec. 23, 2019
Aug. 14, 2019
Apr. 30, 2020
Mar. 31, 2020
May 14, 2020
Dec. 31, 2019
Dec. 31, 2018
Proceeds from subscribed common stock                     $ 18,525,000 $ 2,979,000
Warrant to purchase of common stock                     108,196  
Number of shares services rendered                     $ 1,778,000 $ 1,545,000
Number of preferred stock issued                     598,286  
Number of stock options granted                     2,531,971 1,400,418
Exercise price of common stock granted                     $ 2.07 $ 6.75
Series A Preferred Stock [Member]                        
Number of preferred stock issued             5,030          
Employees and Consultants [Member]                        
Number of stock options granted           1,340,333         2,531,971 1,400,418
Exercise price of common stock granted           $ 1.36         $ 2.07 $ 6.75
Expiration period                     5 years 5 years
Fair value of stock options grants                     $ 4,564,000 $ 9,712,000
Subsequent Event [Member]                        
Common stock, subscribed 845,000     3,392,833       845,000 3,392,833 845,000    
Proceeds from subscribed common stock $ 1,014,000             $ 1,014,000 $ 3,430,000      
Debt description     On April 10, 2020, the board of directors of Verb Technology Company, Inc., a Nevada corporation (the "Company"), approved management's COVID-19 Full Employment and Cash Preservation Plan (the "Plan"), pursuant to which all directors and senior level management would reduce their cash compensation by 25%, and all other employees and consultants would reduce their cash compensation by 20% (the "Cash Reduction Amount") for a period of three months from April 16, 2020 through July 15, 2020 for one category of plan participants, and April 26, 2020 through July 18, 2020 for the other category of participants. The Plan was designed to promote the continued growth of the Company and avoid the lay-offs and staff cut-backs experienced by many companies affected by the COVID-19 economic crisis. The Cash Reduction Amount is to be paid in shares of the Company's common stock (the "Shares") through an allocation of shares from the Company's 2019 Omnibus Incentive Plan (the "Omnibus Incentive Plan") and granted pursuant to stock award agreements entered into effective as of April 10, 2020 (the "Grant Date") between the Company and each of the Company's directors, executive officers, employees, and consultants. The stock award agreements provide that the Shares will vest on July 18, 2020 (the "Vesting Date") as long as the recipient remains in continuous service to the Company during the time from the Grant Date through the Vesting Date. The Shares were valued at $1.198 per share in accordance with the provisions of the Omnibus Incentive Plan, which provides that the value shall be determined based on the volume weighted average price of the Company's common stock during a period of up to the 30-trading days prior to the Grant Date.                  
Number of shares granted of common stock, shares     589,099                  
Number of shares granted of common stock     $ 866,000                  
Subsequent Event [Member] | Paycheck Protection Program [Member]                        
Proceeds from loans   $ 1,218,000                    
Subsequent Event [Member] | Series A Preferred Stock [Member]                        
Number of preferred stock issued                   741,933    
Conversion of preferred stock                   1,150    
Subsequent Event [Member] | Vendors [Member]                        
Number of shares services rendered, shares                   407,633    
Number of shares services rendered                   $ 444,000    
Subsequent Event [Member] | Employee [Member]                        
Number of shares restricted stock award                   11,025    
Subsequent Event [Member] | Employees and Consultants [Member]                        
Number of stock options granted                   323,887    
Exercise price of common stock granted                   $ 1.38    
Expiration period                   5 years    
Stock option vesting, description                   Expire in five years, and vest over a period of four years from grant date.    
Fair value of stock options grants                   $ 437,000    
Subsequent Event [Member] | Series A Stockholders [Member]                        
Warrant to purchase of common stock         2,303,861              
Warrant term         5 years              
Warrant exercise price         $ 1.20              
Fair value derivative liability upon issuance         $ 3,951,000              
Fair value of deemed dividend         $ 3,951,000              
Subsequent Event [Member] | Private Placement [Member]                        
Common per-share price         $ 1.20              
Sale and issuance description         The sale and issuance of up to five million shares of its Common Stock at a per-share price of $1.20, which amount represents a 20% discount to the $1.50 closing price of the Company's Common Stock on that day, and is memorialized by a subscription agreement.              
Common stock, subscribed       4,237,833         4,237,833      
Cash fee aggregate amount       $ 499,000                
Private placement description       The Company's private placement is exempt from the registration requirements of Section 5 of the Securities Act, in reliance on Section 4(a)(2) thereof and/or Rule 506 of Regulation D and Regulation S thereunder, each as promulgated by the SEC. The Company's private placement was managed by the Company; however, in connection with the closings, the Company paid a non-U.S. based consultant (i) as a cash fee, an aggregate amount of $499,000 (or 10% of the gross proceeds of the closings), (ii) as a non-accountable expense allowance, an aggregate of $100,000 (or 2% of the gross proceeds of the closings), (iii) five-year warrants, exercisable for an aggregate of up to 416,199 shares of the Company's Common stock at a cash-only exercise price of $1.92 per share, and (iv) 100,000 shares of the Company's Common Stock.                
Incurred expense       $ 42,000                
Subsequent Event [Member] | Private Placement [Member] | Maximum [Member]                        
Sale and issuance of common stock         5,000,000